They showed that CD148 expression was downregulated in IPF lungs and fibroblasts, and that CD148-deficient fibroblasts exhibited hyperactivated PI3K/Akt/mTOR signalling and reduced autophagy, suggesting that targeting the CD148 phosphatase may represent a therapeutic strategy in IPF. This evidence concerns the gene AKT1 and idiopathic pulmonary fibrosis.